Skip to main content
. 2021 Dec 2;9:769400. doi: 10.3389/fped.2021.769400

Table 3.

Comparison between MAP/MSAP and SAP patients.

MAP/MSAP SAP p-value
Number 47 (52.2%) 43 (47.8%)
Age 29.3 ± 4.2 29.2 ± 3.9 0.937#
BMI 24.9 ± 2.6 24.8 ± 3.8 0.933#
Gestation weeks 32.4 (27.6, 37.3) 35.4 (32.3, 37.3) 0.010a
  The first trimester 1 (2.1%) 0 (0%) 0.52*
    The second trimester 11 (23.4%) 3 (7.0%) 0.032*
    The third trimester 35 (74.5%) 40 (93.0%) 0.018Δ
Gravidity 0.816*
    1st pregnancy 24 (51.1%) 20 (46.5%)
    2nd pregnancy 12 (25.5%) 13 (30.2%)
    3rd pregnancy 7 (14.9%) 7 (16.3%)
    4th pregnancy 3 (6.4%) 1 (2.3%)
    Multiple pregnancy(≥ 5 times) 1 (2.1%) 2 (4.7%)
Parity 0.952*
    Unipara 31 (66.0%) 27 (62.8%)
    2nd para 15 (31.9%) 15 (3.5%)
    3rd para 1 (2.1%) 1 (2.3%)
    History of abortion 11 (23.4%) 11 (25.6%) 0.81Δ
Medical history
    Hypertension 2 (4.3%) 1 (2.3%) 0.53*
    Hyperlipidemia 6 (12.8%) 4 (9.3%) 0.74*
    Hyperglycemia 5 (10.6%) 1 (2.3%) 0.21*
    AP/APIP history 3 (6.4%) 3 (7.0%) 0.62*
    Unhealthy lifestyle 2 (4.3%) 0 (0%) 0.27*
Etiology 0.421Δ
    HTG 33 (70.2%) 25 (58.1%)
    Biliary 8 (17.0%) 12 (27.9%)
    Others 6 (12.8%) 6 (14.0%)
Fetal intrauterine death 10 (21.3%) 18 (41.9%) 0.035Δ

MAP, mild acute pancreatitis; MSAP, moderate-severe acute pancreatitis; SAP, severe acute pancreatitis; BMI, body mass index; AP, acute pancreatitis; APIP, acute pancreatitis in pregnancy; HTG, hypertriglyceridemia; p-values marked by

Δ

were analyzed by Pearson chi-square tests and

*

were analyzed by Fisher's exact tests. p-Values were analyzed by Student t-tests marked by

#

and Mann–Whitney U-tests marked by a.